Trade Bristol Myers BMY

BristolMyers live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

BristolMyers News

Noah Lee 2025 Sep 19, 12:10

Fed Rate Cut: Michael Strain Warns of Potential Policy Reversal in 2026

Ava Grace 2025 Sep 19, 10:10

Fed Rate Cut: Stock Market Outlook Amid Economic Uncertainty

Ghko B 2025 Sep 18, 16:00

SNAP Stock Jumps 5% Today: Why Snap Inc (SNAP) Stock Is Trading Up?

stocks
Frances Wang 2025 Sep 18, 16:00

Trending stocks to watch in Saudi Arabia: QUBT Stock, MSTR, NBIS

stocks
Ghko B 2025 Sep 18, 16:00

Crypto Price Prediction: Ripple (XRP) Price, Cardano (ADA) Price, ETH Price

crypto
Frances Wang 2025 Sep 18, 16:00

Gold CFD Brokers in Saudi Arabia: markets.com, FP Markets, Tickmill

commodity
Magnificent 7 earnings, US and Japan inflation due next week
Neil Wilson 2024 Jul 18, 16:00

Week ahead: Magnificent 7 earnings, 2 key inflation reports

Forex Indices
Wall Street earnings
Neil Wilson 2023 Oct 20, 10:00

Week ahead: Earnings bonanza, ECB decision & US inflation

Forex Indices
Megacap-tech-stocks.jpg
Neil Wilson 2023 Apr 21, 05:00

Week ahead: Megacap tech and 1-in-3 Dow components set to report

2022 Jul 24, 05:42

Week ahead: Fed to hike 100bps into a recession?

Latest news

Show more
Emma Rose 2025 Sep 19, 15:20

Federal Reserve Reform on the Horizon: Price Stability Act Sparks Debate on Central Bank's Mission

Ava Grace 2025 Sep 19, 14:20

Market Review: Fed Rate Cut and Global Economic Trends

Noah Lee 2025 Sep 19, 11:20

US Senators Target Russian Energy Exports with 'Shadow Fleet' Sanctions

Sophia Claire 2025 Sep 19, 04:20

Bank of Japan Holds Rates Steady, Plans to Start Selling ETFs

Liam James 2025 Sep 18, 15:20

Hong Kong Gold Theft Recovered: A Sign of a Growing Global Trend?

Ava Grace 2025 Sep 18, 15:20

US Initial Jobless Claims Fall: A Rebound or a Sign of Stability?

Sophia Claire 2025 Sep 18, 14:20

White House Reacts to Fed Rate Cut: Implications and Analysis

Sophia Claire 2025 Sep 18, 13:20

Swiss Gold Exports to US Plunge Amid Tariff Confusion

Info

Spread

0.29

Spread (%)

0.6453 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

13:31 - 19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

92815867904

Shares Outstanding

2035435838

Earnings Date (Next)

2001-08-07

Div Yield

2025-08-01

Ex-Dividend Date

2025-10-03

Forward annual dividend rate

2.48

Forward annual dividend yield

0.0537

EPS

2.49

Learn more about this instrument

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Frances Wang 2025 Sep 18, 16:00

Gold Price in Saudi Arabia Falls Today: How to Trade Gold CFDs (XAU/USD)?

Commodities
Frances Wang 2025 Sep 18, 16:00

KULR Stock Rises 4% Today: How to Start Trading KULR Stock CFDs in KSA?

Stocks
Frances Wang 2025 Sep 18, 16:00

ETH Price Is Up: Step-by-step Guide for Trading Crypto CFDs in Saudi Arabia

Crypto
Trustpilot